quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:46:56·984d
NEWSRelease
AtaiBeckley Inc. logo
COMPASS Pathways Plc logo
Cybin Inc. logo
+10

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More

ATAI· AtaiBeckley Inc.CMPS· COMPASS Pathways PlcCYBN· Cybin Inc.DRUG· Bright Minds Biosciences Inc.ENVB· Enveric Biosciences Inc.GHRS· GH Research PLC
Health CareConsumer Discretionary
Original source

Companies

  • ATAI
    AtaiBeckley Inc.
    Health Care
  • CMPS
    COMPASS Pathways Plc
    Health Care
  • CYBN
    Cybin Inc.
    Health Care
  • DRUG
    Bright Minds Biosciences Inc.
    Health Care
  • ENVB
    Enveric Biosciences Inc.
    Health Care
  • GHRS
    GH Research PLC
    Health Care
  • HUGE
    FSD Pharma Inc.
    Health Care
  • IXHL
    Incannex Healthcare Inc.
    Health Care
  • LSDI
    Lucy Scientific Discovery Inc.
    Health Care
  • MNMD
    Mind Medicine (MindMed) Inc.
    Health Care
  • SEEL
    Seelos Therapeutics Inc.
    Health Care
  • SILO
    Silo Pharma Inc.
    Consumer Discretionary
  • REUN
    Reunion Neuroscience Inc.
    Health Care

Recent analyst ratings

  • Apr 24CMPSUpdateB. Riley Securities$17.00
  • Apr 13DRUGUpdateJefferies$145.00
  • Mar 27ATAIUpdateDeutsche Bank$12.00
  • Jan 20ATAIUpdateGuggenheim$11.00
  • Dec 10CMPSUpdateOppenheimer$15.00
  • Oct 13MNMDUpdateNeedham$28.00

Related

  • PR2h
    Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher
  • ANALYST4h
    B. Riley Securities initiated coverage on COMPASS Pathways with a new price target
  • SEC20h
    SEC Form S-3 filed by Enveric Biosciences Inc.
  • INSIDER1d
    SEC Form 4 filed by Craig Kevin James
  • SEC1d
    SEC Form DEFA14A filed by AtaiBeckley Inc.
  • SEC1d
    SEC Form DEF 14A filed by AtaiBeckley Inc.
  • SEC2d
    Incannex Healthcare Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR2d
    Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022